Target intelligence / Profile preview

MicroRNA 548a-1 (MIR548A1)

Target
MIR548A1
Molecular classification
microRNA, Non-coding RNA, Other
01

Overview

MicroRNA 548a-1 (MIR548A1) is a short, non-coding RNA belonging to the microRNA (miRNA) family, specifically the mir-548 microRNA precursor family[1][5]. Like other miRNAs, it functions in the post-transcriptional regulation of gene expression by targeting specific messenger RNAs (mRNAs) for degradation or inhibition of translation, thereby influencing cellular processes such as proliferation, apoptosis, differentiation, and drug sensitivity[1]. In cancer, particularly non-small cell lung cancer (NSCLC), miR-548a-1 has been shown to enhance drug sensitivity to cisplatin by targeting the ROBO1 gene and downregulating the Wnt/β-catenin pathway, mechanisms implicated in chemoresistance[2]. MIR548A1 is associated with disease roles primarily in cancer and drug resistance, and its expression may serve as a biomarker for therapeutic response in oncology[1][2].

Other names
hsa-mir-548a-1MIRN548A1miR-548a-1MIR548A1
02

Mechanism of action

Modulation of drug resistance via inhibition of ROBO1 expression and inactivation of the Wnt/β-catenin pathway

03

Biological functions

Post-transcriptional regulation of gene expressionRegulation of mRNA stabilityInhibition of translationInvolvement in cancer cell drug resistanceModulation of Wnt/β-catenin signaling pathway
04

Disease associations

CancerDrug resistance (notably in non-small cell lung cancer)Possibly age-related macular degeneration
05

Safety considerations

Therapeutic modulation of miRNAs carries potential for off-target effects due to their regulation of multiple genesDelivery and specificity challenges in clinical application of miRNA-based therapeutics
06

Interacting drugs

Cisplatin (evidence for interaction through modulation of sensitivity/resistance in non-small cell lung cancer)
07

Biomarkers

miR-548a-1 expression as a biomarker for predicting cisplatin resistance in non-small cell lung cancer

Beyond the preview

Go deeper on MicroRNA 548a-1 (MIR548A1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on MicroRNA 548a-1 (MIR548A1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call